Latest News about AXSM
Recent news which mentions AXSM
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 07, 2022
From Benzinga
Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics
February 02, 2022
From Benzinga
2 Biotech Stocks That Could Be 10-Baggers in 2022
January 26, 2022
From Motley Fool
Why Axsome Therapeutics Climbed Today While the Market Fell
January 18, 2022
From Motley Fool
Buy These Stocks If You Want 126% to 206% Returns, Says Wall Street
January 18, 2022
From Motley Fool
4 Biotech Acquisitions We'd Like to See in 2022
January 14, 2022
From Motley Fool
My 3 Top Biopharma Stock Picks for 2022
January 09, 2022
From Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
January 07, 2022
From Benzinga
3 Biotech Stocks That Sank in 2021 but Could Soar in 2022
December 26, 2021
From Motley Fool
8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022
December 07, 2021
From Motley Fool
Why Axsome Therapeutics Stock Took a Step Backwards This Week
December 02, 2021
Tickers
AXSM
From Motley Fool
3 Biotech Stocks That Can Double Your Money, According to Wall Street
November 25, 2021
From Motley Fool
2 Top Biotech Stocks Ready for a Bull Run
November 24, 2021
From Motley Fool
Is Compass Pathways Stock a Once-in-a-Lifetime Bargain?
November 11, 2021
From Motley Fool
Axsome Therapeutics, inc (AXSM) Q3 2021 Earnings Call Transcript
November 08, 2021
Tickers
AXSM
From Motley Fool
2 Growth Stocks That Could Deliver 1,000% Returns
October 31, 2021
From Motley Fool
2 Biotech Stocks Poised for Jaw-Dropping Growth
October 17, 2021
From Motley Fool
From Motley Fool
Why Axsome Therapeutics Stock Rocketed Higher This Week
October 15, 2021
Tickers
AXSM
From Motley Fool
45 Biggest Movers From Yesterday
October 13, 2021
From Benzinga
Why Axsome Therapeutics Stock Caught Fire in September
October 06, 2021
Tickers
AXSM
From Motley Fool
2 Best Biotech Stocks to Buy Right Now
September 25, 2021
From Motley Fool
Why Wall Street Thinks This Biotech Stock Can Triple Your Money
September 23, 2021
Tickers
AXSM
From Motley Fool
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
3 Healthcare Stocks That Might Skyrocket When COVID Is Over
September 07, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.